Robert MacLeod
Fortune : - $ au 31/08/2026
Fortune : - $ au 31/08/2026
Robert A. MacLeod started working at ADARx Pharmaceuticals, Inc. in 2023.
The current position held is Chief Scientific Officer at ADARx Pharmaceuticals, Inc. since 2023.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 25/09/2026 | 0 ( -.--% ) | - $ | 31/08/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| ADARX PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 01/01/2023 |
| Sociétés | Poste | Fin |
|---|---|---|
Flamingo Therapeutics BV
Flamingo Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Provides RNA therapeutic drug development services | Directeur Technique/Scientifique/R&D | 01/12/2022 |
| IONIS PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 01/09/2021 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
Ionis Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops antisense drugs | Health Technology |
McGill University
McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Concordia University
Concordia University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ADARx Pharmaceuticals, Inc.
ADARx Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage pipeline that develops RNA medicines for diseases | Commercial Services |
Flamingo Therapeutics BV
Flamingo Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Provides RNA therapeutic drug development services | Commercial Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national